The FDA approved neffy epinephrine nasal spray, and it was the top allergy/asthma story in 2024. Image: Adobe Stock “We commend the FDA's decision to approve neffy, which offers the food allergy ...
Many people are still affected with asthma after exposure to chemicals at work despite known risks and recommendations for protective equipment. Many people are still affected with asthma after ...
and he denied hospitalization for asthma. In addition, patient reported increased nasal congestion, postnasal drip and anosmia, despite taking fluticasone nasal spray daily and loratadine daily.